Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

Completed · Not applicable

Conditions studied: Relapsing-remitting Multiple Sclerosis

In brief

Between 15-20% of MS patients decide not to initiate disease modifying therapies after being diagnosed with MS. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in initiating disease modifying medications than patients given brief education and treatment as usual.

Key facts

Study ID

NCT02010554

Run by

University of Missouri, Kansas City

People needed

40

Starts

2013-12-01

Expected to finish

2015-09-01

Last updated by the study team

2015-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of relapsing remitting MS based on established guidelines
• Not taking recommended therapy
• Provider recommendation for DMT use
• At least 18 years of age
• Access to a telephone
• English speaking

Where it is running

• University of Missouri-Kansas City — Kansas City, Missouri, United States
• Kessler Rehabilitation Institute — West Orange, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.